Benjamin A. Adam

Dr. Benjamin A. Adam

Dr. Benjamin A. Adam, MD, FRCPC is an Anatomical Pathologist and Assistant Professor in the Department of Laboratory Medicine and Pathology at the University of Alberta. He completed medical school and residency training in Anatomical Pathology at the University of Alberta, followed by subspecialty training in renal pathology at Harvard Medical School/Massachusetts General Hospital, cardiothoracic pathology at Toronto General Hospital, and transplantation pathology at the University of Pittsburgh Medical Center. His research is focused on molecular transplantation pathology, including the use of cutting-edge gene expression technologies to diagnose and assess allograft rejection, infection, and ex vivo perfusion-related injury and repair. He has authored over 25 peer-reviewed journal articles and traveled throughout the world to present and lecture on the topics of his research and clinical expertise.

Robert B. Colvin

Dr. Robert B. Colvin

Dr. Robert B. Colvin is the Benjamin Castleman Distinguished Professor of Pathology at Harvard Medical School and Pathologist in Chief, emeritus, Massachusetts General Hospital in Boston USA. He has a longstanding interest in the mechanisms of graft rejection and acceptance and the pathological analysis of renal biopsies. He published extensively in the field and his research has been continually funded by the National Institutes of Health since 1976. He has trained over 60 fellows.

Anthony (Jake) Demetris

Dr. Anthony (Jake) Demetris

Professor of Pathology, University of Pittsburgh, Pittsburgh, PA
Dr. Demetris has more than 30 years’ experience as a researcher and academic pathologist with a specialty practice devoted primarily to transplantation and inflammatory pathology, including liver, kidney, heart, intestine, and composite tissue allografts. Currently, Dr. Demetris is the director of the Division of Hepatic and Transplantation Pathology at the University of Pittsburgh Medical Center; Director of the Banff Liver Working Group on Liver Allograft Pathology, and the Director of the Liver Tissue Core for the Immune Tolerance Network, Transmedics Trials in Organ Perfusion and the CTOT Pediatric Heart Transplantation.

Cinthia Drachenberg

Dr. Cinthia Drachenberg

Dr. Drachenberg is the primary renal and pancreas transplant pathologist at the University of Maryland Transplant Program since 1992 and Director of the Department of Pathology Electron Microscopy Laboratory since 1998. In the area of pancreas transplantation, Dr. Drachenberg has lead the Banff groups that defined the clinicopathological guidelines for the diagnosis of acute and chronic T-cell mediated and antibody mediated allograft rejections. More recent work relates to morphological correlations with partial and complete pancreatic islet failure after transplantation. Dr. Drachenberg has authored more than 200 peer reviewed scientific articles and multiple book chapters on the pathology of renal and pancreas transplantation.

Mark Haas

Dr. Mark Haas

Cedars-Sinai Medical Center, Department of Pathology & Laboratory Medicine
My academic career has had two overlapping phases. My initial research focus was on ion transport, particularly Na-K-Cl cotransport and its regulation, in a number of different cell and tissue types including red blood cells and secretory and absorptive epithelia. During this time I also gained expertise as a diagnostic renal pathologist and initiated a number of clinico-pathologic studies of glomerular diseases, including focal segmental glomerulosclerosis, IgA nephropathy, and lupus nephritis. For the past 20 years, my investigative work has focused primarily on the pathology of and clinic-pathological correlations in glomerular diseases and renal transplantation, with ongoing collaborations with investigators studying experimental models of lupus nephritis and other glomerular diseases. I have gained considerable expertise as a renal pathologist and my work in both glomerular diseases and renal transplantation is widely cited. I have been an invited speaker at numerous national and international meetings focusing on nephrology, pathology, and transplantation, and was the lead organizer of the 2013-2019 Banff Conferences on Allograft Pathology. In 2012, I was awarded the Jacob Churg Award of the Renal Pathology Society for outstanding achievement in renal pathology.

Michael Mengel

Dr. Michael Mengel

Dr Mengel is Chair and Medical Director for Laboratory Medicine and Pathology at the University of Alberta and with Alberta Precision Laboratories in Edmonton, Canada. As a sub-specialized Transplantation and Renal Pathologist, Dr. Mengel is engaged in various international sub-specialty societies related to nephropathology and organ transplantation: past Chair Transplant Diagnostics Community of Practice in the American Society of Transplantation; Board Chair International Banff Foundation for Allograft Pathology; Past-President Canadian Society of Transplantation; President Renal Pathology Society. He studied medicine at the Semmelweiss University in Budapest, Hungary before going on to specialise in pathology and further in transplantation pathology and nephropathology. Before moving to Edmonton provided transplant pathology service at the Hannover Medical School, Germany. Dr. Mengel has published widely in his field and his current work is focused on applying molecular techniques to biopsy specimens, with the aim to increase diagnostic precision in organ transplantation.

Peter Nickerson

Dr. Peter Nickerson

Dr. Peter Nickerson is a Distinguished Professor of Internal Medicine and Immunology and the Vice-Dean Research, Rady Faculty of Health Sciences at the University of Manitoba. He is the Medical Director of Transplant Manitoba and the Medical Advisor, Organ Donation and Transplantation Division, Canadian Blood Services (CBS).

Dr. Nickerson holds the Flynn Family Chair in Renal Transplantation at the University of Manitoba. Funded by the CIHR and NIH, his research program focuses on mechanisms underlying acute and chronic transplant rejection; developing non-invasive techniques for the diagnosis of renal allograft rejection; and health care system design to enhance access to transplant.

Kim Solez

Dr. Kim Solez

Kim Solez, M.D. has been an international leader in pathology for over three decades. He is Professor of Pathology at the University of Alberta and the creator of the NEPHROL Email discussion group, the Banff Classification of Transplant Pathology https://youtu.be/3pv58_3tWHA, and The Technology and Future of Medicine Course, and has over 1,200 YouTube videos, and over 105,000 images online on social media. He created the new medical discipline of tissue engineering pathology, and has drawn attention to the fact that single cell transcriptomics, the human cell atlas project, will double the number of recognized cell types in every major organ changing entirely the stories we tell ourselves about normal development and human disease. At the ASHI Banff meeting in Pittsburgh in September 2019 he led discussions about digital pathology, AI, and regenerative medicine in transplant pathology, and presented the first digital pathology white paper in transplant pathology.